Sökresultat

Every person ages, yet only some develop Parkinson’s Disease, and scientists still don’t know why. A new international effort involving a research team from Lund University aims to uncover what makes certain aging brains more vulnerable than others, focusing on the epigenetic changes that accompany growing older. Their work is supported by a new 81 million SEK grant from the Aligning Science Acros

https://www.stemcellcenter.lu.se/article/81-million-sek-drives-new-international-effort-study-aging-and-epigenetic-changes-parkinsons-disease - 2026-09-05

Researchers at the Lund Stem Cell Center, Lund University, have discovered that a population of B cells formed shortly after birth store long-term immune memory and, in mice, can give rise to leukemia much later in life. Published in Cell Reports, the findings reveal how immune events at the very beginning of life can leave lasting biological imprints, linking early development to disease in old a

https://www.stemcellcenter.lu.se/article/early-life-b-cells-can-drive-leukemia-later-life - 2026-09-05

The Lund Stem Cell Center at Lund University is a partner in BEYOND, a new European postdoctoral training programme designed to prepare the next generation of researchers in advanced cell and gene therapies. Coordinated by Fondazione Telethon, the programme is supported by €6 million from the Horizon Europe Marie Skłodowska Curie Actions (MSCA) COFUND scheme and will fund 35 international postdoct

https://www.stemcellcenter.lu.se/article/lund-stem-cell-center-joins-beyond-european-postdoctoral-programme-advanced-therapies - 2026-09-05

The STEM PD clinical trial, a stem cell–based approach for Parkinson’s disease, is entering a new phase in its development. In May 2026, Cellular Intelligence, an AI native biotech company, announced that it has acquired global rights from the Danish pharmaceutical company, Novo Nordisk, to further advance the clinical development of the STEM PD programme. STEM‑PD is among a small number of plurip

https://www.stemcellcenter.lu.se/article/stem-pd-enters-new-chapter-cellular-intelligence-acquires-global-rights-advance-stem-cell-therapy - 2026-09-05

When research findings are ready to make the leap from the lab to the patient, the requirements become much stricter. That is precisely where many promising projects start to falter. “We want to be the bridge between research and the patient, so that promising projects don’t get stuck in that difficult transition,” says Sara Nolbrant, director of the new pre-GMP facility. And with that, she disapp

https://www.stemcellcenter.lu.se/article/training-ground-cell-and-gene-therapies-new-pre-gmp-facility-aims-smooth-path-idea-patient - 2026-09-05

Lund Stem Cell Center continues to grow as a leading hub for interdisciplinary stem cell research, welcoming four new principal investigators into its research community. Together, they bring specialised expertise spanning molecular and cell biology, immunology and bioengineering, further strengthening the Center’s scientific scope and possibilities for collaboration. How cells protect their DNA,

https://www.stemcellcenter.lu.se/article/lund-stem-cell-center-welcomes-four-new-research-group-leaders - 2026-09-05

A landmark study led from Lund, has shown that transplanting stem-cell derived dopamine progenitor cells into the brain is feasible. Eight patients were transplanted in the first clinical trial, and no serious side effects linked to the transplanted cells were seen during the first year of follow up. The results are published in Nature Medicine. In Parkinson’s disease, patients lose nerve cells in

https://www.stemcellcenter.lu.se/article/stem-pd-announces-first-human-clinical-trial-results-parkinsons-disease-cell-therapy - 2026-09-05

When researchers at Stem Cell Center investigated how the molecule UM171 works, a molecule used to make blood stem cells multiply, they made an unexpected connection. The results provide new insights into how one of the most common malignant brain tumours in children could be treated in the future. UM171 is a synthetic molecule developed by researchers at Université de Montréal. In stem cell resea

https://www.stemcellcenter.lu.se/article/unexpected-discovery-reveals-mechanism-behind-brain-tumour-development - 2026-09-05

This article is over 5 years old, and the information may therefore be outdated. Welcome to Lund Stem Cell Center's new homepage! Here you will find our research groups, information on our core facilities, research school, latest news and events, job vacancies and more. 

https://www.stemcellcenter.lu.se/article/welcome-new-homepage-lund-stem-cell-center - 2026-09-05

This article is over 5 years old, and the information may therefore be outdated. Principal Investigators Daniella Ottosson and Charlotta Böiers have been accepted to join Lund Stem Cell Center.A warm welcome to the Ottosson and Böiers groups. To learn more about their research, the following Stem Cell Talks have been scheduled: Wednesday 25th September: Principal Investigator Daniella Ottosson. De

https://www.stemcellcenter.lu.se/article/welcome-two-new-principal-investigators-lund-stem-cell-center - 2026-09-05

This article is over 5 years old, and the information may therefore be outdated. Prof. Johan Jakobsson and Assoc. Prof. Agnete Kirkeby from Lund Stem Cell Center and University of Copenhagen, along with co-applicants Prof. Roger Barker from Cambridge, UK and Assoc. Prof. Molly Hammell from Cold Spring Harbour Laboratory, US, have been awarded a prestigious grant from the Aligning Science Across Pa

https://www.medicine.lu.se/article/researchers-investigate-role-transposable-elements-neuroinflammation-and-parkinsons-disease - 2026-09-05

This article is over 5 years old, and the information may therefore be outdated. The University Board has today decided to recommend the dean of the Faculty of Medicine, Erik Renström, as the new vice-chancellor of Lund University for the term of office 2021 to 2026. "This is a big step. I am humble and it is with deep respect I am looking forward to this task", comments Erik Renström.He is also h

https://www.medicine.lu.se/article/erik-renstrom-proposed-new-vice-chancellor - 2026-09-05

This article is over 5 years old, and the information may therefore be outdated. Johan Richter's research has resulted in the successful development of gene therapy for the hereditary disease malignant infantile osteopetrosis. For the past few years, the research group has established a collaboration with an American biotech company and all the permits needed to start a clinical trial have now bee

https://www.medicine.lu.se/article/successful-biotech-collaboration-brings-gene-therapy-project-clinic - 2026-09-05

This article is over 5 years old, and the information may therefore be outdated. Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating. Researchers at Lund University in Sweden have now identified bi

https://www.medicine.lu.se/article/metformin-type-2-diabetes-patients-or-not-researchers-now-have-answer - 2026-09-05

This article is over 5 years old, and the information may therefore be outdated. A large proportion of our elite athletes are suffering psychological distress during the COVID-19 pandemic, with more women than men reporting adverse reactions. This is demonstrated by the study Psychological Distress and Problem Gambling in Elite Athletes during COVID-19 Restrictions: A Web Survey in Top Leagues of

https://www.medicine.lu.se/article/many-elite-athletes-feeling-psychological-distress-during-pandemic - 2026-09-05

This article is over 5 years old, and the information may therefore be outdated. Lund University researchers have developed an analytical model that can effectively detect and identify gene mutations in breast tumours. In the study, which is the largest of its kind anywhere in the world, they are now reporting results from 3,200 breast cancer patients. To assist them, they have utilised a techniqu

https://www.medicine.lu.se/article/new-analytical-method-benefits-breast-cancer-patients - 2026-09-05

This article is over 5 years old, and the information may therefore be outdated. A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine. Every year, about 20 children in Sweden are diagnosed with neuroblastoma, an aggressiv

https://www.medicine.lu.se/article/promising-treatment-aggressive-childhood-cancer - 2026-09-05

This article is over 5 years old, and the information may therefore be outdated. Agnete Kirkeby is working to repair the brain with stem cells. “The goal of our research is to understand how the human brain is formed and how it functions. And how we can repair it by generating new cells in the lab.” Agnete Kirkeby is one of the reserchers at Wallenberg Centre for Molecular Medicine at Lund Univers

https://www.medicine.lu.se/article/meet-weeks-wallenberg-researcher-agnete-kirkeby - 2026-09-05

This article is over 5 years old, and the information may therefore be outdated. Should patients with separate variants of type 2 diabetes be treated with different types of drugs? Researchers at Lund University in Sweden and Skåne University Hospital will attempt to answer that question in a new study. Type 2 diabetes is one of the fastest growing diseases in the world. It is estimated that over

https://www.medicine.lu.se/article/new-study-personalized-type-2-diabetes-treatment-launched - 2026-09-05

This article is over 5 years old, and the information may therefore be outdated. Niklas Mattsson-Carlgren is searching for underlying causes for Alzheimer’s Disease. “I am motivated by the possibility that my work may make difference for patients with Alzheimer’s Disease.” Niklas Mattsson-Carlgren is one of the reserchers at Wallenberg Centre for Molecular Medicine at Lund University (WCMM LU). Th

https://www.medicine.lu.se/article/meet-weeks-wallenberg-researcher-niklas-mattsson-carlgren - 2026-09-05